2013 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
George M. Shaw mainly focuses on Virology, Virus, Genetics, Immunology and Viral replication. His Virology research is multidisciplinary, incorporating perspectives in Epitope and Antibody. George M. Shaw has included themes like Viral evolution, Genome, Gene, Provirus and Immune system in his Virus study.
His Immunology research is multidisciplinary, incorporating elements of Cytotoxic T cell and Acquired immunodeficiency syndrome. His research integrates issues of V3 loop, Enfuvirtide and In vivo in his study of Viral replication. His studies examine the connections between Simian immunodeficiency virus and genetics, as well as such issues in Immunodeficiency, with regards to Primate.
George M. Shaw spends much of his time researching Virology, Virus, Antibody, Immunology and Genetics. His Virology research includes themes of Epitope, Gene and Immune system. As a part of the same scientific family, George M. Shaw mostly works in the field of Virus, focusing on Phylogenetic tree and, on occasion, Phylogenetics.
His Antibody research is multidisciplinary, incorporating perspectives in Molecular biology and Antigen. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Acquired immunodeficiency syndrome. His Simian immunodeficiency virus study incorporates themes from Simian, Lentivirus and Immunodeficiency.
His primary scientific interests are in Virology, Antibody, Virus, Immunology and Immune system. His research links Immunodeficiency with Virology. His Antibody research integrates issues from Heterologous and Vaccination.
George M. Shaw studies Viral load, a branch of Virus. His Immunology course of study focuses on Cytotoxic T cell and CD8. The concepts of his Immune system study are interwoven with issues in Viral evolution, Host and Rhesus macaque.
His primary areas of study are Virology, Antibody, Virus, Viral replication and Neutralizing antibody. George M. Shaw studies Virology, namely Neutralization. The Antibody study combines topics in areas such as Gene, Binding site and Simian immunodeficiency virus.
His Virus study is concerned with the field of Immunology as a whole. His work carried out in the field of Viral replication brings together such families of science as Chronic infection, Molecular biology and T cell. His study looks at the intersection of Neutralizing antibody and topics like Recombinant DNA with Genetic variation, Recombination, Genotype, Cell-mediated cytotoxicity and Homologous chromosome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Viral dynamics in human immunodeficiency virus type 1 infection
Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson.
Antibody neutralization and escape by HIV-1
Xiping Wei;Julie M. Decker;Shuyi Wang;Huxiong Hui.
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
Feng Gao;Elizabeth Bailes;David L. Robertson;Yalu Chen.
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
P Borrow;H Lewicki;B H Hahn;G M Shaw.
Journal of Virology (1994)
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
Xiping Wei;Julie M. Decker;Hongmei Liu;Zee Zhang.
Antimicrobial Agents and Chemotherapy (2002)
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
Piatak M;Saag Ms;Yang Lc;Clark Sj.
AIDS as a Zoonosis: Scientific and Public Health Implications
BH Hahn;GM Shaw;KM De Cock;Paul Sharp.
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
Persephone Borrow;Hanna Lewicki;Xiping Wei;Marc S. Horwitz.
Nature Medicine (1997)
POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY
J M Kilby;S Hopkins;T M Venetta;B DiMassimo.
Nature Medicine (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: